Burnham faces pressure to abandon UK-US NHS drug deal amid health warnings

Health organizations are urging Andy Burnham to terminate the controversial UK-US NHS drug deal, which they claim prioritizes pharmaceutical profits over patient welfare. The call comes as Burnham, anticipated to succeed Keir Starmer as Labour leader, prepares for a pivotal moment in UK politics. The letter, coordinated by the SOS NHS coalition, highlights alarming projections of 229,000 excess deaths by 2036 if the deal remains intact.

Concerns Over Drug Pricing and NHS Funding

Signed in December, the agreement is defended by ministers as a means to enhance British drug exports to the US and provide access to crucial medicines. However, critics argue that it will require the NHS to divert £45 billion from essential services over the next decade, ultimately jeopardizing patient care.

Recent analysis from academics at the University of York, University of Liverpool, and Christchurch Hospital in New Zealand indicates that the financial burden imposed by the deal could lead to a significant decline in NHS resources. This situation raises concerns about the overall public health landscape in the UK.

Health Groups Demand Action from Burnham

In a letter seen by the Guardian, 19 health organizations are calling for a decisive break from the current policy, urging Burnham to focus on the long-term viability of the NHS. Signatories, including Medact and Doctors in Unite, stress the need to re-evaluate recent NHS job cuts and the expansion of private providers.

Dr. Tony O’Sullivan, co-chair of Keep Our NHS Public, criticized the deal, stating, “Donald Trump’s demands for higher drug prices are set to drain an estimated £45 billion from the NHS over the next decade.” He emphasized the urgent need for Burnham to listen to campaigners and prioritize patient welfare over corporate interests.

Potential Impact on Patient Care

The deal's implications extend beyond financial metrics, with campaigners like Hope Worsdale highlighting the potential for avoidable deaths among NHS patients. Worsdale described the agreement as a “deeply shocking betrayal” of the NHS and called on Burnham to ensure life-saving investments in healthcare.

Burnham has not publicly stated his position regarding the UK-US trade deal or whether he intends to scrap it. His past as health secretary included a commitment to making the NHS the preferred provider of care, aiming to counteract increasing privatization.

• £45 billion diverted from NHS services by 2036
• 229,000 projected excess deaths due to reduced funding
• 19 health organizations urge policy change
• Call for re-evaluation of private provider expansion